TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30606085

Group type: EXPERIMENTAL
Intervention: Veinplicity
Number of subjects: 20

Group type: COMPARATOR
Intervention: Heat packs
Number of subjects: 20
Study: 29414272

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 304
Study: 26482004

Group type: EXPERIMENTAL
Intervention: Home-based, nurse-led health program (family-care team provision, physiological rehabilitation, emotion-release management, informal social support system, and follow-up monitoring)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Conventional nursing education
Number of subjects: 226
Study: 24506226

Group type: EXPERIMENTAL
Intervention: Soft Seal®
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: i-gel™
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: AuraOnce™
Number of subjects: 40

Group type: COMPARATOR
Intervention: Concurrent chest compressions
Number of subjects: 40
Study: 23134222

Group type: EXPERIMENTAL
Intervention: Thiamine-depleted lake trout injected with TNP-LPS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiamine-replete lake trout injected with TNP-KLH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiamine-depleted lake trout injected with TNP-KLH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiamine-depleted lake trout
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiamine-replete lake trout
Number of subjects: 0
Study: 20130603

Group type: EXPERIMENTAL
Intervention: 6-mercaptopurine/methotrexate (MTX) maintenance therapy
Number of subjects: 59
Study: 19230269

Group type: EXPERIMENTAL
Intervention: Memory intervention based on self-efficacy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 16706649

Group type: EXPERIMENTAL
Intervention: Antioxidant/NO‐modulating fermented papaya preparation (FPP) 9 g/day for 4 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 12710789

Group type: EXPERIMENTAL
Intervention: Head-elevated position
Number of subjects: 55

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 55
Study: 10843451

Group type: EXPERIMENTAL
Intervention: BCG plus epirubicin
Number of subjects: 41

Group type: COMPARATOR
Intervention: BCG alone
Number of subjects: 41
Study: 9166203

Group type: EXPERIMENTAL
Intervention: Immediate treatment
Number of subjects: 435

Group type: COMPARATOR
Intervention: Deferred treatment
Number of subjects: 435
Study: 8404096

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (PY) 30 mg orally three times a day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study: 3780824

Group type: EXPERIMENTAL
Intervention: Metoclopramide 1 and 2 mg/kg i.v. X 5
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard antiemetics in low doses on demand
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Self-reporting of nausea using a visual analogue scale (VAS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High dose metoclopramide
Number of subjects: 15
Study: 29204710

Group type: EXPERIMENTAL
Intervention: SymptomCare@Home (SCH)
Number of subjects: 252
Study: 27576880

Group type: EXPERIMENTAL
Intervention: PCNL using split Amplatz sheath (group 2)
Number of subjects: 72

Group type: COMPARATOR
Intervention: PCNL using intact Amplatz sheath (group 1)
Number of subjects: 72
Study: 25007868

Group type: COMPARATOR
Intervention: Group B: 120 kV, 40 % ASIR
Number of subjects: 44

Group type: COMPARATOR
Intervention: Group C: 100 kV, 40 % ASIR
Number of subjects: 44

Group type: COMPARATOR
Intervention: Group D: 80 kV, 40 % ASIR
Number of subjects: 44
Study: 22631865

Group type: EXPERIMENTAL
Intervention: Immediate postpartum etonogestrel implant (IPI) insertion
Number of subjects: 396

Group type: COMPARATOR
Intervention: Other methods (control group)
Number of subjects: 396
Study: 20400451

Group type: EXPERIMENTAL
Intervention: Peritoneal Dialysis (PD)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Haemodialysis (HD)
Number of subjects: 140
Study: 17924051

Group type: EXPERIMENTAL
Intervention: Osteoporosis diagnosis
Number of subjects: 2187

Group type: EXPERIMENTAL
Intervention: Treatment with bisphosphonates
Number of subjects: 2187

Group type: EXPERIMENTAL
Intervention: Calcium and/or vitamin D supplementation
Number of subjects: 2187

Group type: EXPERIMENTAL
Intervention: Treatment for hip fractures
Number of subjects: 2187

Group type: EXPERIMENTAL
Intervention: Untreated men with clinical fragility fractures
Number of subjects: 2187
Study: 15915072

Group type: EXPERIMENTAL
Intervention: RV dysfunction with LV/RV <2
Number of subjects: 99

Group type: COMPARATOR
Intervention: RV dysfunction with LV/RV >=2
Number of subjects: 99
Study: 12830461

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 10650359

Group type: EXPERIMENTAL
Intervention: Locally delivered doxycycline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scaling and root planing
Number of subjects: 0
Study: 9252001

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo apparatus
Number of subjects: 94
Study: 2005924

Group type: COMPARATOR
Intervention: Primidone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Phenobarbital
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Primidone and Phenobarbital
Number of subjects: 15
Study: 6404289

Group type: EXPERIMENTAL
Intervention: Intravenous glyceryl trinitrate
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 85
Study: 31484028

Group type: EXPERIMENTAL
Intervention: Adolescent/Adult Sensory Profile (AASP)
Number of subjects: 787
Study: 28780512

Group type: EXPERIMENTAL
Intervention: 30 mg/kg dapirolizumab pegol followed by 15 mg/kg every 2 weeks for 10 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Matched placebo regimen
Number of subjects: 24
Study: 24702239

Group type: EXPERIMENTAL
Intervention: 4% articaine buccal infiltration (1.8 mL with 1:100,000 epinephrine)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 2% lidocaine inferior alveolar nerve block (1.8 mL with 1:100,000 epinephrine)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 4% articaine buccal infiltration
Number of subjects: 50

Group type: COMPARATOR
Intervention: 2% lidocaine inferior alveolar nerve block
Number of subjects: 50
Study: 23078578

Group type: EXPERIMENTAL
Intervention: Sleep deprivation (34 hours without sleep)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (normal sleep from 23:00 to 07:00 h)
Number of subjects: 10
Study: 22120094

Group type: EXPERIMENTAL
Intervention: Tolvaptan 7.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tolvaptan 15 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Furosemide (control)
Number of subjects: 0
Study: 19592176

Group type: EXPERIMENTAL
Intervention: D-Cycloserine (DCS)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 16845915

Group type: EXPERIMENTAL
Intervention: Sevoflurane-nitrous oxide
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol-nitrous oxide
Number of subjects: 80
Study: 15533731

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 11046202

Group type: EXPERIMENTAL
Intervention: 5% albumin solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch solution
Number of subjects: 20
Study: 9073135

Group type: EXPERIMENTAL
Intervention: Discontinuous polymeric enteral nutrition (1665 kcal/day, through nasogastric tube)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Nil by mouth (control group)
Number of subjects: 22
Study: 8375360

Group type: EXPERIMENTAL
Intervention: Phase related external suction (PRES) baroreceptor stimulation
Number of subjects: 7

Group type: COMPARATOR
Intervention: Baroreceptor inhibition
Number of subjects: 7
Study: 3531141

Group type: EXPERIMENTAL
Intervention: 200 mg/day drug
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 100 mg/day drug
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 200 mg/day drug (therapeutic)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (prophylactic)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (therapeutic)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 200 mg/day drug (tolerance study)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (tolerance study)
Number of subjects: 38
Study: 28993537

Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28124590

Group type: EXPERIMENTAL
Intervention: Dementia Screening Questionnaire for Individuals with Intellectual Disabilities (DSQIID-I)
Number of subjects: 200
Study: 25581217

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) 0.3g at 37 Hz for 10 minutes daily
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo (sham WBV)
Number of subjects: 174
Study: 23301010

Group type: EXPERIMENTAL
Intervention: Sensory behavioral tasks (including learning tasks with and without visual feedback and simple somatosensory input)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Visual feedback task
Number of subjects: 40
Study: 21492437

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 30
Study: 18571210

Group type: EXPERIMENTAL
Intervention: Olibra fat emulsion (test yoghurt)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (test yoghurt)
Number of subjects: 41
Study: 17135810

Group type: EXPERIMENTAL
Intervention: Mail-In Cognitive Function Screening Instrument (MCFSI)
Number of subjects: 640
Study: 14680080

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: COMPARATOR
Intervention: Salbutamol (200 microg)
Number of subjects: 29
Study: 12071899

Group type: EXPERIMENTAL
Intervention: PEP plus information booklet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Information booklet only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 9686665

Group type: EXPERIMENTAL
Intervention: Specific cellular immunity in children with zoster
Number of subjects: 13

Group type: COMPARATOR
Intervention: Matched controls (N=8)
Number of subjects: 13
Study: 8135446

Group type: EXPERIMENTAL
Intervention: Cervical bruit present
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cervical bruit absent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cervical bruit combined with four other clinical characteristics
Number of subjects: 0
Study: 2572251

Group type: EXPERIMENTAL
Intervention: Xamoterol (200 mg twice daily)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Digoxin (0.125 mg twice daily)
Number of subjects: 1000
Study: 31005425

Group type: EXPERIMENTAL
Intervention: Transbronchial cryobiopsy (TBC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Transbronchial cryobiopsy (TBC) after 2015
Number of subjects: 24
Study: 27913163

Group type: EXPERIMENTAL
Intervention: Centralized reminder/recall (C-R/R)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Practice-based reminder/recall (PB-R/R)
Number of subjects: 15
Study: 25924776

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 150

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 150
Study: 23489394

Group type: EXPERIMENTAL
Intervention: Computerised cognitive behavioural therapy (CCBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive Mental Training (PosMT)
Number of subjects: 0
Study: 21235825

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program for 3 years
Number of subjects: 304

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program for 3 years (sub-analysis for BMI > 22.5 kg/m2)
Number of subjects: 304
Study: 19234828

Group type: EXPERIMENTAL
Intervention: Hyperventilation (tidal volume of 10-12 ml x kg(-1) for 16 hours or more)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard ventilation (tidal volume of 6-8 ml x kg(-1))
Number of subjects: 22
Study: 17355378

Group type: EXPERIMENTAL
Intervention: Pregnancy and STD prevention counseling (adapted from motivational interviewing)
Number of subjects: 764

Group type: COMPARATOR
Intervention: General health counseling (Control)
Number of subjects: 764
Study: 15573643

Group type: EXPERIMENTAL
Intervention: Hand care regimen with moisturizer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group using a regimen without moisturizer
Number of subjects: 0
Study: 11494079

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg initially, increased to 100 mg or decreased to 25 mg based on efficacy and toleration)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 9541846

Group type: EXPERIMENTAL
Intervention: Iopromid with 370 mg iodine/ml (viscosity 9.9 mPas, osmolality 770 mOsmol/kg H2O)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iodixanol with 270 mg iodine/ml (viscosity 5.8 mPas, osmolality 290 mOsmol/kg H2O)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iopentol with 150 mg iodine/ml (viscosity 1.7 mPas, osmolality 340 mOsmol/kg H2O)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-viscosity radiocontrast agents
Number of subjects: 0
Study: 7995781

Group type: EXPERIMENTAL
Intervention: Intravenous metoprolol (10‐15 mg i.v.)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intravenous atropine (0.03 mg/kg i.v.)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 9
Study: 30219434

Group type: EXPERIMENTAL
Intervention: Heated yoga at 40.5°C (n=21)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Thermoneutral yoga at 23°C (n=14)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Time control (n=19)
Number of subjects: 54
Study: 27759410

Group type: EXPERIMENTAL
Intervention: Bionator with expansion screw
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: All-patient group
Number of subjects: 42
Study: 24682346

Group type: EXPERIMENTAL
Intervention: MPCs (25 million)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (medium)
Number of subjects: 30
Study: 22132809

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/day
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (lactose capsule)
Number of subjects: 65
Study: 20592514

Group type: EXPERIMENTAL
Intervention: UW Cores system
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intervention team
Number of subjects: 14
Study: 18243581

Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG)
Number of subjects: 2311

Group type: COMPARATOR
Intervention: Reading achievement program
Number of subjects: 2311

Group type: COMPARATOR
Intervention: Standard program
Number of subjects: 2311
Study: 16183442

Group type: EXPERIMENTAL
Intervention: Bullard laryngoscopy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Macintosh laryngoscopy
Number of subjects: 21
Study: 12834519

Group type: EXPERIMENTAL
Intervention: EXER (supervised exercise training)
Number of subjects: 28

Group type: COMPARATOR
Intervention: HOME (home exercise program)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: EXER
Number of subjects: 28

Group type: COMPARATOR
Intervention: HOME
Number of subjects: 28
Study: 10371541

Group type: EXPERIMENTAL
Intervention: Ibuprofen treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gradual dose escalation of interferon beta-1b
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of ibuprofen treatment and gradual dose escalation of interferon beta-1b
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8664112

Group type: EXPERIMENTAL
Intervention: Continuous hyperfractionated accelerated radiation therapy (CHART)
Number of subjects: 1481

Group type: COMPARATOR
Intervention: Conventional radiotherapy (Control)
Number of subjects: 1481

Group type: EXPERIMENTAL
Intervention: CHART
Number of subjects: 1481
Study: 1768559

Group type: EXPERIMENTAL
Intervention: Prochlorperazine (PCZ) 12.5 mg i.v.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prochlorperazine (PCZ) 50 mg oral
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prochlorperazine (PCZ) 25 mg twice daily for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prochlorperazine (PCZ) single doses
Number of subjects: 0
Study: 6344550

Group type: EXPERIMENTAL
Intervention: Urabe Am 9 strain of live attenuated mumps vaccine
Number of subjects: 118

Group type: COMPARATOR
Intervention: Jeryl Lynn strain of live attenuated mumps vaccine
Number of subjects: 118
Study: 31427751

Group type: EXPERIMENTAL
Intervention: Immunomodulatory drugs (Anti-IL-6 antibodies)
Number of subjects: 10743

Group type: EXPERIMENTAL
Intervention: Immunomodulatory drugs (Anti-IL-12/23 antibody)
Number of subjects: 10743

Group type: COMPARATOR
Intervention: Immunomodulatory drugs (general)
Number of subjects: 10743
Study: 27511921

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR) program
Number of subjects: 200

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 200
Study: 27543343

Group type: EXPERIMENTAL
Intervention: TAU plus six sessions of clinical emotional freedom techniques (EFT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) wait-list group
Number of subjects: 21
Study: 24291366

Group type: EXPERIMENTAL
Intervention: Carvedilol 12.5mg daily
Number of subjects: 209

Group type: COMPARATOR
Intervention: Endoscopic variceal ligation (EVL)
Number of subjects: 209
Study: 21919823

Group type: EXPERIMENTAL
Intervention: Subcutaneous alemtuzumab 10 mg three times a week for 18 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Subcutaneous alemtuzumab 30 mg once weekly after lymphocyte count reduction by 1 Log in 18 patients
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Subcutaneous alemtuzumab
Number of subjects: 39
Study: 20584263

Group type: EXPERIMENTAL
Intervention: Tagatose at 250 mOsmol
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Fructose at 250 mOsmol
Number of subjects: 31

Group type: COMPARATOR
Intervention: All hexoses at 500 mOsmol
Number of subjects: 31

Group type: COMPARATOR
Intervention: Lactulose and saline at 500 mOsmol
Number of subjects: 31
Study: 18758414

Group type: EXPERIMENTAL
Intervention: Combined anesthesia (isoflurane anesthesia combined with thoracic epidural analgesia)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isoflurane/fentanyl anesthesia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Combined anesthesia and Isoflurane/fentanyl anesthesia
Number of subjects: 60
Study: 16002961

Group type: EXPERIMENTAL
Intervention: EBUS-D
Number of subjects: 55

Group type: COMPARATOR
Intervention: EBUS-S
Number of subjects: 55
Study: 12466508

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine plus ivermectin
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine alone
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 2500
Study: 10730524

Group type: EXPERIMENTAL
Intervention: Fresh Frozen Plasma (FFP)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Haemaccel
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Normal Saline (NSS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 64
Study: 7718260

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 1674060

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for severe stenosis (70-99%)
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Control group (no surgery) for severe stenosis (70-99%)
Number of subjects: 2200
Study: 7470781

Group type: EXPERIMENTAL
Intervention: Amipaque (metrizamide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amipaque (metrizamide) 370 mg iodine/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amipaque (metrizamide) 300 mg iodine/ml
Number of subjects: 0
Study: 31170151

Group type: EXPERIMENTAL
Intervention: Previous experience of physical IPV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Previous experience of emotional IPV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home violence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High self-efficacy
Number of subjects: 0
Study: 28779269

Group type: EXPERIMENTAL
Intervention: Non-heme iron (FeSO4, 195 mg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Heme iron (heme-iron-polypeptide, HIP, 31.5 to 94.5 mg/day)
Number of subjects: 14
Study: 27129315

Group type: EXPERIMENTAL
Intervention: Upper tertile U-Cd (≥0.42 μg/g Cr)
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Increased U-Cd concentrations
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Dietary intake of micronutrients (calcium, magnesium, zinc, and selenium)
Number of subjects: 653

Group type: COMPARATOR
Intervention: Preeclamptic women
Number of subjects: 653
Study: 24367008

Group type: EXPERIMENTAL
Intervention: Nitrates (specifically intravenous nitroglycerin infusion)
Number of subjects: 199

Group type: COMPARATOR
Intervention: No nitrates (control group)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Nitrates (general use)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin infusion
Number of subjects: 199
Study: 22077907

Group type: EXPERIMENTAL
Intervention: Supported Employment (SE)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional Vocational Rehabilitation (TVR)
Number of subjects: 100
Study: 20392784

Group type: EXPERIMENTAL
Intervention: Locomotor imagery training (five days a week for four weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Locomotor imagery training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (regular physical therapy)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 17582407

Group type: EXPERIMENTAL
Intervention: Combination therapy consisting of prednisolone, L-thyroxine, and conjugated estrogen/medroxyprogesterone acetate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0